All In Biotech

Drug Trial Radar · NCT07254702

Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

Prospective Safety Cohort Study VLA1553-406

Last checked: Nov 19, 2026Latest source record: Jul 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

5,000

Planned (sponsor's estimate)

Start

Feb 2, 2026

Primary completion

Oct 31, 2026

Study completion Feb 28, 2027

Sponsor

Lead sponsor
Valneva Austria GmbHIndustry
Sponsor type
Industry
Collaborators
Butantan Foundation; Coalition for Epidemic Preparedness Innovations
First posted
Nov 28, 2025

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is an observational study with primary data collection, which will combine a prospective safety cohort study and an SCRI study.

Conditions

  • Chikungunya Virus Infection

Interventions

  • Live-attenuated CHIKV vaccine VLA1553Biological

    Non-interventional study: VLA1553 is used in the pilot vaccination strategy which will start along with this observational study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To estimate the incidence rates of a predefined set of AEs which constitute safety concerns according to the VLA1553 Risk Management Plan following the administration of the live-attenuated VLA1553 vaccineTime frame: From enrollment until Day 60

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras

    Belo Horizonte, Minas Gerais, Brazil

  • Fundação Faculdade Regional De Medicina De São José Do Rio Preto

    São Pedro, São Paulo, Brazil

  • Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus

    Laranjeiras, Sergipe, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.